Fred Hutchinson Cancer Research Center biostatistician Dr. Yingqi Zhao has been awarded the Dr. Charles A. Coltman Jr. Fellowship, which recognizes and funds prolific early- and mid-career scientists from affiliated institutions within SWOG, a national clinical trials network. The Coltman Fellowship, which is sponsored by SWOG’s public charity, The Hope Foundation, includes a two-year, $50,000-a-year grant to support the development of cutting-edge clinical trials within…
Read More
The National Institutes of Health has awarded a $6.5 million, five-year grant to the University of Washington and partner institutions to establish the Center for Reproducible Biomedical Modeling. The center’s primary goal is to develop more effective predictive models of biological systems, which are used in research and medicine. “We are delighted that the NIH has made this award,” said Herbert Sauro,…
Read More
Seattle Children’s Research Institute is launching a clinical trial that will examine a new kind of cancer-fighting treatment. The treatment is a type of CAR T immunotherapy, which reprograms a person’s immune cells to find and destroy cancer. CAR T therapies have found early success in blood cancers, including leukemia and lymphoma, but have run into obstacles when it comes…
Read More

New Tools for Syphilis Research

Syphilis research has been severely limited by the necessity to propagate Treponema pallidumin vivo in rabbits. After decades of erroneous or irreproducible reports of cultivation of T. pallidum, the recent very convincing report of its successful long-term in vitro propagation opens numerous opportunities for development of genetictools for studying pathogenesis and protein function, antigenic variation, and surface exposure of antigens. The possibility of more rapid isolation of…
Read More
Scientists have completed a major effort to map the regulatory landscape of the mouse genome at a single-cell resolution. The team applied a special assay that they had previously developed to profile a genomic feature called chromatin accessibility. The researchers were interested in how the DNA winding, wrapping and packaging into what is termed chromatin influences what genetic information is…
Read More
More than a dozen area tech and biotech companies are supporting Fred Hutch Obliteride this year to help accelerate the lifesaving work at Fred Hutchinson Cancer Research Center. Amazon, Microsoft, Seattle Genetics, Juno, Blue Nile and Lyft are a few of the companies helping sponsor the event and have rallied large teams of employees to participate and fundraise. Other companies including Adaptive Technologies,…
Read More
The Damon Runyon Cancer Research Foundation has named Fred Hutchinson Cancer Research Center’s Dr. Jay F. Sarthy as one of five outstanding young scientists to receive the prestigious Damon Runyon-Sohn Pediatric Cancer Fellowship Award. He will receive $231,000 over four years to study pediatric brain cancers. Under the mentorship of geneticist Dr. Steven Henikoff and pediatric neuro-oncologist Dr. Jim Olson of the Hutch, Sarthy will aim…
Read More

Iodide Improves Outcome After Acute Myocardial Infarction in Rats and Pigs

In this study, we tested whether iodide would reduce heart damage in rat and pig models of acute myocardial infarction as a risk analysis for a human trial. Acute myocardial infarction was induced by temporary ligation of the coronary artery followed by reperfusion. Iodide was administered orally in rats or IV in rats and pigs just prior to reperfusion. Damage was assessed by blood…
Read More
Five years ago, IDRI (Infectious Disease Research Institute) moved into a state-of-the-art lab at 1616 Eastlake Avenue East, which is owned and operated by Alexandria Real Estate Equities, Inc. (NYSE: ARE), in the heart of Seattle’s growing South Lake Union life sciences hub. Today, the IDRI-Alexandria partnership continues as IDRI is hosts a summer intern from the University of Washington’s…
Read More